Advertisement

Fourteen years of pancreatic surgery for malignancy among ACS-NSQIP centers: Trends in major morbidity and mortality

      Abstract

      Background

      The American College of Surgeons National Surgical Quality Improvement Program was established to help participating hospitals track and report surgical complications with the goal of improving surgical care. We sought to determine whether this has led to improvements in surgical outcomes for pancreatic malignancies.

      Methods

      Patients with pancreatic malignancies who underwent surgical resection were identified from the American College of Surgeons National Surgical Quality Improvement Program database (2006–2019). Thirty-day postoperative major morbidity and mortality were analyzed by year. Major morbidity included organ and deep surgical site infection, venous thromboembolism, cardiac event, pneumonia, acute renal failure, sepsis, and respiratory failure.

      Results

      Of the 28,888 patients identified, 51% were male, the median age was 68, 74.3% underwent a pancreaticoduodenectomy, and 25.7% underwent a distal pancreatectomy. Among patients who underwent a pancreaticoduodenectomy, there was a significant increase in major morbidity (annual percent change 0.77, P = .012) driven by increases in organ space surgical site infection (annual percent change 3.52, P < .001) and venous thromboembolism (annual percent change 4.72, P = .005). However, there was a decrease in postoperative mortality (annual percent change -4.58, P = .001). For distal pancreatectomy patients, there was no change in rates of overall major morbidity (annual percent change -1.35, P = .08) or mortality (annual percent change -3.21, P = .25).

      Conclusion

      Although major morbidity and mortality have not significantly changed for distal pancreatectomy patients, mortality has steadily decreased for patients undergoing pancreaticoduodenectomy, despite an increase in major morbidity. Whether this trend reflects a change in patient selection, an increase in detection of postoperative morbidities and/or an improvement in mitigation of these morbidities warrants further study.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cameron J.L.
        • Riall T.S.
        • Coleman J.
        • Belcher K.A.
        One thousand consecutive pancreaticoduodenectomies.
        Ann Surg. 2006; 244: 10-15
        • Büchler M.W.
        • Wagner M.
        • Schmied B.M.
        • Uhl W.
        • Friess H.
        • Z’graggen K.
        Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy.
        Arch Surg. 2003; 138 (discussion 1315): 1310-1314
        • Wegner R.E.
        • Verma V.
        • Hasan S.
        • et al.
        Incidence and risk factors for post-operative mortality, hospitalization, and readmission rates following pancreatic cancer resection.
        J Gastrointest Oncol. 2019; 10: 1080-1093
        • Richter A.
        • Niedergethmann M.
        • Sturm J.W.
        • Lorenz D.
        • Post S.
        • Trede M.
        Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
        World J Surg. 2003; 27: 324-329
        • Schmidt C.M.
        • Powell E.S.
        • Yiannoutsos C.T.
        • et al.
        Pancreaticoduodenectomy: a 20-year experience in 516 patients.
        Arch Surg. 2004; 139 (discussion 725–727): 718-725
        • Pecorelli N.
        • Nobile S.
        • Partelli S.
        • et al.
        Enhanced recovery pathways in pancreatic surgery: state of the art.
        World J Gastroenterol. 2016; 22: 6456-6468
        • Soufi M.
        • Deperalta D.K.
        • Simpson R.
        • et al.
        Novel preoperative patient-centered surgical wellness program impacts length of stay following pancreatectomy.
        Anticancer Res. 2021; 41: 1895-1901
        • Takahashi Y.
        • Takesue Y.
        • Fujiwara M.
        • et al.
        Risk factors for surgical site infection after major hepatobiliary and pancreatic surgery.
        J Infect Chemother. 2018; 24: 739-743
        • Maggino L.
        • Liu J.B.
        • Ecker B.L.
        • Pitt H.A.
        • Vollmer C.M.
        Impact of operative time on outcomes after pancreatic resection: a risk-adjusted analysis using the American College of Surgeons NSQIP database.
        J Am Coll Surg. 2018; 226: 844-857.e3
        • Hu B.Y.
        • Wan T.
        • Zhang W.Z.
        • Dong J.H.
        Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy.
        World J Gastroenterol. 2016; 22: 7797-7805
        • Schlick C.J.R.
        • Merkow R.P.
        • Yang A.D.
        • Bentrem D.J.
        Post-discharge venous thromboembolism after pancreatectomy for malignancy: predicting risk based on preoperative, intraoperative, and postoperative factors.
        J Surg Oncol. 2020; https://doi.org/10.1002/jso.26046
        • Maggino L.
        • Liu J.B.
        • Thompson V.M.
        • Pitt H.A.
        • Ko C.Y.
        • Vollmer C.M.
        Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database.
        HPB (Oxford). 2019; 21: 1773-1783
        • American College of Surgeons National Surgical Quality Improvement Program
        User guide for the 2006 participant use data file.
        • American College of Surgeons National Surgical Quality Improvement Program
        • American College of Surgeons National Surgical Quality Improvement Program
        User guide for the 2019 participant use data file.
        • Surveillance, Epidemiology, and End Results (SEER) Program
        Joinpoint Trend Analysis Software 2021.
        • Gleeson E.M.
        • Shaikh M.F.
        • Shewokis P.A.
        • et al.
        WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database.
        Surgery. 2016; 160: 1279-1287
        • Ahola R.
        • Sand J.
        • Laukkarinen J.
        Centralization of pancreatic surgery improves results: review.
        Scand J Surg. 2020; 109: 4-10
        • Eppsteiner R.W.
        • Csikesz N.G.
        • McPhee J.T.
        • Tseng J.F.
        • Shah S.A.
        Surgeon volume impacts hospital mortality for pancreatic resection.
        Ann Surg. 2009; 249: 635-640
        • Schmidt C.M.
        • Turrini O.
        • Parikh P.
        • et al.
        Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience.
        Arch Surg. 2010; 145: 634-640
        • Gooiker G.A.
        • Lemmens V.E.
        • Besselink M.G.
        • et al.
        Impact of centralization of pancreatic cancer surgery on resection rates and survival.
        Br J Surg. 2014; 101: 1000-1005
        • Lidsky M.E.
        • Sun Z.
        • Nussbaum D.P.
        • Adam M.A.
        • Speicher P.J.
        • Blazer D.G.
        Going the extra mile: improved survival for pancreatic cancer patients traveling to high-volume centers.
        Ann Surg. 2017; 266: 333-338
        • Kazanjian K.K.
        • Hines O.J.
        • Eibl G.
        • Reber H.A.
        Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients.
        Arch Surg. Sep 2005; 140 (discussion 854–856): 849-854
        • Bassi C.
        • Falconi M.
        • Salvia R.
        • Mascetta G.
        • Molinari E.
        • Pederzoli P.
        Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients.
        Dig Surg. 2001; 18 (discussion 458): 453-457
        • Balcom J.H.
        • Rattner D.W.
        • Warshaw A.L.
        • Chang Y.
        • Fernandez-del Castillo C.
        Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.
        Arch Surg. 2001; 136: 391-398
        • El Nakeeb A.
        • Hamed H.
        • Shehta A.
        • et al.
        Impact of obesity on surgical outcomes post-pancreaticoduodenectomy: a case-control study.
        Int J Surg. 2014; 12: 488-493
        • Bassi C.
        • Marchegiani G.
        • Dervenis C.
        • et al.
        The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after.
        Surgery. 2017; 161: 584-591
        • Machado N.O.
        Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and management-review.
        Int J Surg Oncol. 2012; 2012: 602478
        • Rasmussen M.S.
        • Jorgensen L.N.
        • Wille-Jørgensen P.
        • et al.
        Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study.
        J Thromb Haemost. 2006; 4: 2384-2390
        • Network N.C.C.
        Cancer-associated venous thromboembolic disease.
        • Ruff S.M.
        • Ayabe R.I.
        • Wach M.M.
        • et al.
        Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons.
        J Thromb Thrombolysis. 2019; 48: 119-124
        • Kodalek L.M.
        • Haut E.R.
        Screening and diagnosis of VTE: the more you look, the more you find?.
        Curr Trauma Rep. 2016; 2: 29-34
        • Lee J.C.
        • Ro Y.S.
        • Cho J.
        • et al.
        Characteristics of venous thromboembolism in pancreatic adenocarcinoma in East Asian ethnics: a large population-based observational study.
        Medicine (Baltimore). 2016; 95e3472
        • Mahan C.E.
        • Holdsworth M.T.
        • Welch S.M.
        • Borrego M.
        • Spyropoulos A.C.
        Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event.
        Thromb Haemost. 2011; 106: 405-415
        • Ri M.
        • Aikou S.
        • Seto Y.
        Obesity as a surgical risk factor.
        Ann Gastroenterol Surg. 2018; 2: 13-21
        • Huttunen R.
        • Syrjänen J.
        Obesity and the risk and outcome of infection.
        Int J Obes (Lond). 2013; 37: 333-340
        • Martin E.T.
        • Kaye K.S.
        • Knott C.
        • et al.
        Diabetes and risk of surgical site infection: a systematic review and meta-analysis.
        Infect Control Hosp Epidemiol. 2016; 37: 88-99
        • Ismael H.
        • Horst M.
        • Farooq M.
        • Jordon J.
        • Patton J.H.
        • Rubinfeld I.S.
        Adverse effects of preoperative steroid use on surgical outcomes.
        Am J Surg. 2011; 201 (discussion 308–309): 305-308
        • Nagle R.T.
        • Leiby B.E.
        • Lavu H.
        • Rosato E.L.
        • Yeo C.J.
        • Winter J.M.
        Pneumonia is associated with a high risk of mortality after pancreaticoduodenectomy.
        Surgery. 2017; 161: 959-967
        • Ji H.B.
        • Zhu W.T.
        • Wei Q.
        • Wang X.X.
        • Wang H.B.
        • Chen Q.P.
        Impact of enhanced recovery after surgery programs on pancreatic surgery: a meta-analysis.
        World J Gastroenterol. 2018; 24: 1666-1678
        • Poruk K.E.
        • Lin J.A.
        • Cooper M.A.
        • et al.
        A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy.
        HPB (Oxford). 2016; 18: 893-899
        • Oba A.
        • Ho F.
        • Bao Q.R.
        • Al-Musawi M.H.
        • Schulick R.D.
        • Del Chiaro M.
        Neoadjuvant treatment in pancreatic cancer.
        Front Oncol. 2020; 10: 245
        • American College of Surgeons National Surgical Quality Improvement Program
        User guide for the 2019 ACS NSQIP procedure targeted participant use data file.